drug

Cognitive Behavioural Case Management

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Orygen
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
The Staged Treatment in Early Psychosis Study
NCT02751632Phase 3Completed

KOLs & investigators

1
Patrick McGorry, MD, PhDKOL score 8

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Orygen
company
trial
The Staged Treatment in Early Psychosis Study
PHASE3
trial
indication
Clinical High Risk
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
Personality Disorders
indication
KOL
Patrick McGorry, MD, PhD
KOL score 8
person